eribullin

eribulin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for eribullin, covering 2022-11-23 to 2022-11-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer [Phase 2]